A cost evaluation of the georgia stroke and heart attack prevention program

Preventing Chronic Disease

Volumn 3, Issue 1, 2006, Pages

  Rein, David B ^b   Constantine, Roberta T ^b   Orenstein, Diane ^a   Chen, Hong ^b   Jones, Patricia ^a   Nell Brownstein, J ^a   Farris, Rosanne ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; HYPERTENSION; POVERTY; PREVENTIVE HEALTH SERVICE; UNITED STATES;

ANTIHYPERTENSIVE AGENTS; CEREBROVASCULAR ACCIDENT; CORONARY DISEASE; COST-BENEFIT ANALYSIS; GEORGIA; HUMANS; HYPERTENSION; POVERTY; PREVENTIVE HEALTH SERVICES;

EID: 33747432293     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290(2):199-206.
2. Centers for Disease Control and Prevention. Racial/ethnic disparities in prevalence, treatment, and control of hypertension - United States, 1999-2002. MMWR Morb Mortal Wkly Rep 2005;54(1):7-9.
3. National Institutes of Health. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Rockville (MD): U.S. Department of Health and Human Services; 2003. NIH Publication No. 04-5230.
4. Bell AC, Adair LS, Popkin BM. Understanding the role of mediating risk factors and proxy effects in the association between socio-economic status and untreated hypertension. Soc Sci Med 2004 Jul;59(2):275-283.
5. The sixth report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46.
6. He J, Whelton PK. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. J Hypertens Suppl 1999;17(2): S7-13.
7. ALLHAT Collaborative Research Group. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA 2002;288(23):2998-3007.
8. Gandelman G, Aronow WS, Varma R. Prevalence of adequate blood pressure control in self-pay or Medicare patients versus Medicaid or private insurance patients with systemic hypertension followed in a university cardiology or general medicine clinic. Am J Cardiol 2004;94(6):815-6.
9. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract 1998;1:2-4
10. Georgia Department of Human Resources. Cardiovascular health - stroke and heart attack prevention program (SHAPP) [Internet]. Atlanta (GA): Georgia Department of Human Resources, Division of Public Health; 2002. Available from: URL: http://health.state.ga.us/programs/cardio/shapp.asp.
11. Klungel OH, Stricker BH, Paes AH, Seidell JC, Bakker A, Vok Z, et al. Excess stroke among hyper-tensive men and women attributable to undertreatment of hypertension. Stroke 1999;30:1312-8.
12. Flack JM, Casciano R, Casciano J, Doyle J, Arikian S, Tang S, et al. Cardiovascular disease costs associated with uncontrolled hypertension. Manag Care Interface 2002;15(11):28-36.
13. Tierney WM, Brunt M, Kesterson J, Zhou XH, L'Italien G, Lapuerta P. Quantifying risk of adverse clinical events with one set of vital signs among primary care patients with hypertension. Ann Fam Med 2004;2:209-17.
14. Mcmanus RJ, Mant J, Oakes R, Roalfe A, Hobbs FD. A randomised controlled trial of patient held targets and self monitoring in the control of hypertension: targets and self monitoring in hypertension (Tasminh) trial. Heart 2004;90: A38.
15. Gold MR, Siegal JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
16. MEPS Puf Data Files [2001 Data File]. Rockville (MD): Agency for Healthcare Research and Quality; 2004.
17. Perneger TV, Klag MJ, Feldman HI, Whelton PK. Projections of hypertension-related renal disease in middle-aged residents of the United States. JAMA 1993;269:1272-7.
18. Smith DH, Gullion CM, Nichols G, Keith DS, Brown JB. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 2004;15:1300-6.